Patents by Inventor Colin E. Rowlings

Colin E. Rowlings has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TABLET FOR PULSED DELIVERY
    Publication number: 20140212490
    Abstract: A pharmaceutical tablet comprising an immediate release portion containing an active ingredient and a delayed release portion, wherein the delayed release portion comprises an enteric-coated layer and within the enteric-coated layer there is at least one member selected from the group consisting of enteric-coated microparticle dosage forms containing an active ingredient and enteric-coated mini-tablet dosage forms containing an active ingredient, is disclosed.
    Type: Application
    Filed: March 28, 2014
    Publication date: July 31, 2014
    Applicant: SHIONOGI INC.
    Inventors: Bruce Cao, Sandra E. Wassink, Donald J. Treacy, JR., Beth A. Burnside, Colin E. Rowlings, John A. Bonck
  • Tablet for pulsed delivery
    Patent number: 8715727
    Abstract: A pharmaceutical tablet comprising an immediate release portion containing an active ingredient and a delayed release portion, wherein the delayed release portion comprises an enteric-coated layer and within the enteric-coated layer there is at least one member selected from the group consisting of enteric-coated microparticle dosage forms containing an active ingredient and enteric-coated mini-tablet dosage forms containing an active ingredient, is disclosed.
    Type: Grant
    Filed: July 1, 2005
    Date of Patent: May 6, 2014
    Assignee: Shionogi Inc.
    Inventors: Bruce Cao, Sandra E. Wassink, Donald J. Treacy, Jr., Beth A. Burnside, Colin E. Rowlings, John A. Bonck
  • COMPOSITIONS COMPRISING 4-(2-(5-BROMO-4-(1-CYCLOPROPYLNAPHTHALEN-4-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACETAMIDO)-3-CHLOROBENZOIC ACID AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, AND METHODS FOR PREPARING AND USING SAME
    Publication number: 20110244049
    Abstract: The present invention relates to compositions comprising 4-(2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4H-1,2,4-triazol-3-ylthio)acetamido)-3-chlorobenzoic acid or pharmaceutically acceptable salts thereof, and to the preparation and use of such compositions, in particular for the treatment of diseases.
    Type: Application
    Filed: October 23, 2009
    Publication date: October 6, 2011
    Applicant: ARDEA BIOSCIENCES INC.
    Inventors: Barry D. Quart, Colin E. Rowlings
  • Pulsatile transdermally administered antigens and adjuvants
    Publication number: 20040253249
    Abstract: Methods for triggering immunogenic responses and for eliciting improved immunogenic responses to immunogens in humans or animals through pulsatile transdermal delivery of antigens and adjuvants to the Langerhans cells of the skin, are disclosed.
    Type: Application
    Filed: April 2, 2004
    Publication date: December 16, 2004
    Inventors: Edward M. Rudnic, Colin E. Rowlings, Beth A. Burnside, Robert J. Guttendorf